HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Nephroblastoma — Clinical Guidelines

Overview

Wilms tumour, or nephroblastoma, is a pediatric renal malignancy arising from developmental anomalies of the kidney, often linked to genetic syndromes such as WAGR syndrome (Wilms tumour, Aniridia, Genitourinary anomalies, and mental Retardation) 4. It typically affects children under five years old and can present with associated ocular anomalies like aniridia or genitourinary abnormalities 1 2 4.

Diagnosis

Clinical Presentation: Abdominal mass, hematuria, and hypertension 7.

Imaging: Ultrasound and CT scans are crucial for initial assessment and staging 6.

Biopsy: Histopathological examination confirms diagnosis, noting rare cases of neuronal and glial differentiation 3.

Genetic Testing: Consider in cases with associated syndromes like Perlman or Wiedemann-Beckwith syndromes 2.

Management

Surgical Resection: Nephrectomy or partial nephrectomy, depending on tumour stage and extent 7.

Adjuvant Therapy: Chemotherapy post-surgery, typically using agents like vincristine, doxorubicin, and dactinomycin 7.

Radiation Therapy: Reserved for specific high-risk cases or sarcomatous components 7.

Interdisciplinary Approach: Essential for comprehensive care involving pediatric surgeons, oncologists, and radiologists 7.

Special Populations

Pediatrics: Primary population affected, with tailored treatment protocols 7.

Associated Syndromes: Management may require additional considerations for Perlman or Wiedemann-Beckwith syndromes 2.

Key Recommendations

Multidisciplinary Team Approach for Treatment: Essential for optimal outcomes in Wilms tumour management (Evidence: Strong 7).

Chemotherapy Post-Surgery: Standard adjuvant chemotherapy regimen should be administered to reduce recurrence risk (Evidence: Strong 7).

Genetic Evaluation in Syndromic Cases: Evaluate for associated genetic syndromes to guide comprehensive care (Evidence: Moderate 2).

References

1 Harendra de Silva DG, Jayantha UK, Liyanaarachchi S. Wilms tumour associated with unilateral dysplasia of the iris. The Ceylon medical journal 1992. link 2 Grundy RG, Pritchard J, Baraitser M, Risdon A, Robards M. Perlman and Wiedemann-Beckwith syndromes: two distinct conditions associated with Wilms' tumour. European journal of pediatrics 1992. link 3 Kumar RV, Venugopal AR, Dastur DK. Histomorphology of Wilms' tumour. Indian journal of pathology & microbiology 1989. link 4 Hastie ND, Bickmore W, Pritchard-Jones K, Porteous DJ, van Heyningen V. Wilms tumour: a developmental anomaly. Princess Takamatsu symposia 1989. link 5 Ishii E, Fujimoto J, Tanaka S, Hata J. Immunohistochemical analysis on normal nephrogenesis and Wilms' tumour using monoclonal antibodies reactive with lymphohaemopoietic antigens. Virchows Archiv. A, Pathological anatomy and histopathology 1987. link 6 Wilson C, Drainer IK. An unusual case of Wilms' tumour in a horseshoe kidney. Zeitschrift fur Kinderchirurgie : organ der Deutschen, der Schweizerischen und der Osterreichischen Gesellschaft fur Kinderchirurgie = Surgery in infancy and childhood 1986. link 7 Ringert RH, Hartung R, Havers W. Interdisciplinary treatment of Wilms' tumour. British journal of urology 1983. link 8 de Martinville B, Francke U. The c-Ha-ras1, insulin and beta-globin loci map outside the deletion associated with aniridia-Wilms' tumour. Nature 1983. link 9 Huerre C, Despoisse S, Gilgenkrantz S, Lenoir GM, Junien C. c-Ha-ras1 is not deleted in aniridia-Wilms' tumour association. Nature 1983. link

Nephroblastoma